Amir Smith's Nature Journal
2021 draft budget will reflect financing needs of the (...)
Email Compromise Scheme Targets PPP Loan Recipients
PETS: Smart Collar Translates Dog Barks
St. Louis lawmakers want marker at slave pen site near Busch
AUDIO: Charles County Sheriff's Deputies Investigating a Murder in Bryans Road
Shearer singles out Arsenal star that wowed him « Arsenal News
Channel Great Sage With This Soft and Squishy Rimuru Replica
Rainbow Six Siege update: Today’s PS4 and Xbox One patch notes confirmed
American Home Furnishings HOF ceremony slated for June
2 Hudson Valley Restaurants Close Due to COVID-19
The 2021 Radar Screen
Finance, Audit and Risk Committee (C-FAR)
Grand Marais mayor's dog survives attack by wolves
State Capitol's on Lockdown
Carolyn Sue Colon, 82 – WBNOWQCT
Mark Wright's mum Carol enjoys dog walk with daughters Jess and Natalya after coronavirus battle
Powered by curiosity: Alumna and leading battery researcher Jie Xiao
Plunged into virus 'dark winter,' Biden must lead US ou...
Preston woman facing charges in incident involving firearm
Driver charged after alleged failed burnouts, video
"The low dose/standard dose regimen, although it has been quoted to have an efficacy of 90%, this is confounded by the fact that the interval between the first and second dose was quite long," Pirmohamed told a news conference.The UK's COVID-19 vaccine chair, Wei Shen Lim, said a single dose of Oxford/AstraZeneca's vaccine was around 70% effective from 21 days until a second dose was given.Britain’s Medicines and Healthcare Products Regulatory Agency (MHRA) recommended an interval of between 4-12 weeks between doses of the AstraZeneca/Oxford vaccine and also updated its guidance for a second dose of the Pfizer-BioNTech shot saying it could be administered within 12 weeks, rather than the 21 days originally recommended.Pfizer sounded cautious on the prospect of shifting the schedule of its second dose, noting it had not been evaluated on different dosing schedules.
Jeremy Farrar, director of health research foundation Wellcome, said a new trial might be needed to give clearer data on the best timing of a second dose."This would be best achieved by a randomised trial on the timing of the second dose.